Can a simple blood test predict health decline in elderly patients?

NCT ID NCT07435467

Recruiting now Knowledge-focused Sponsor: Istituto Nazionale di Ricovero e Cura per Anziani Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study aims to see if blood markers for Alzheimer's and brain injury can help predict death and hospital readmission in older patients. Researchers will follow 400 hospitalized seniors, including those with neurological issues or dementia. The goal is to develop a tool that uses these blood tests to better understand patient outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Alzheimer disease delirium dementia encephalitis hemorrhagic stroke Inflammation ischemic stroke meningitis Nerve Degeneration

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ALZHEIMER DISEASE OLD AGE; DEMENTIA

Contacts and locations

Locations

IRCCS INRCA Hospital
RECRUITING

Ancona, Italy
IRCCS INRCA Hospital
RECRUITING

Fermo, Italy
Policlinico Universitario
RECRUITING

Messina, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.